Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 24
8-K
Corporate Presentation May 2024
13 May 24
ARS
2023 FY
Annual report to shareholders
8 May 24
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
8 May 24
8-K
Departure of Directors or Certain Officers
29 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
10-K/A
2023 FY
Annual report (amended)
22 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
29 Feb 24
S-8
Registration of securities for employees
13 Nov 23
8-K
Regulation FD Disclosure
6 Nov 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
1 Nov 23
8-K
Innoviva Appoints Stephen Basso as Chief Financial Officer
25 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Aug 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
2 Aug 23
8-K
Departure of Directors or Certain Officers
11 Jul 23
8-K
Corporate Presentation May 2023
24 May 23
8-K
Submission of Matters to a Vote of Security Holders
23 May 23
DEFA14A
Additional proxy soliciting materials
17 May 23
8-K
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent
9 May 23
10-Q
2023 Q1
Quarterly report
9 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
8-K
Innoviva Announces Retirement of Board Chairman
28 Apr 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
10-K/A
2022 FY
Annual report (amended)
20 Mar 23
8-K
Innoviva Reports Fourth Quarter 2022 Financial Results and Highlights Recent Company Progress
28 Feb 23
10-K
2022 FY
Annual report
28 Feb 23
8-K
Departure of Directors or Certain Officers
4 Jan 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
8-K
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
9 Nov 22
8-K/A
Completion of Acquisition or Disposition of Assets
28 Oct 22
8-K
Regulation FD Disclosure
14 Sep 22
8-K
Other Events
23 Aug 22
8-K
Completion of Acquisition or Disposition of Assets
22 Aug 22
Latest ownership filings
4
Sapna Srivastava
20 Jun 24
4
Derek A Small
20 Jun 24
4
Sarah J. Schlesinger
20 Jun 24
4
Kostas D Odysseas
20 Jun 24
4
Jules Haimovitz
20 Jun 24
4
Mark DiPaolo
20 Jun 24
4
Matthew Ronsheim
21 May 24
4
Marianne Zhen
21 May 24
SC 13G
FRANKLIN RESOURCES INC
13 May 24
SC 13D
FRANKLIN RESOURCES INC
8 May 24
3
Derek A Small
1 May 24
4
Stephen Basso
7 Mar 24
4
Matthew Ronsheim
7 Mar 24
4
Marianne Zhen
7 Mar 24
4
Pavel Raifeld
7 Mar 24
SC 13D/A
Armata Pharmaceuticals, Inc.
4 Mar 24
4
Matthew Ronsheim
22 Feb 24
4
Marianne Zhen
22 Feb 24
SC 13G/A
PUTNAM INVESTMENTS LLC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
SC 13G
DIMENSIONAL FUND ADVISORS LP
9 Feb 24
4
Matthew Ronsheim
22 Jan 24
SC 13G/A
BlackRock Inc.
22 Jan 24
3
Matthew Ronsheim
10 Jan 24
4
Marianne Zhen
22 Nov 23
4
Marianne Zhen
17 Nov 23
4
Stephen Basso
31 Aug 23
3
Stephen Basso
31 Aug 23
4
Marianne Zhen
31 Aug 23
4
Margaret Koziel
2 Aug 23
3
Margaret Koziel
2 Aug 23
SC 13D/A
Armata Pharmaceuticals, Inc.
11 Jul 23
4
ALEXANDER J DENNER
20 Jun 23
4
ALEXANDER J DENNER
7 Jun 23
4
ALEXANDER J DENNER
30 May 23
4
Sapna Srivastava
24 May 23
4
Deborah Birx
24 May 23
4
Sarah J. Schlesinger
24 May 23
4
Jules Haimovitz
24 May 23